The DOI matches its Crossref record; 288 of the 289 references it cites were found in a registry or an index.
DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis
Abstract
Two systems are essential in humans for genome integrity, DNA repair and apoptosis. Cells that are defective in DNA repair tend to accumulate excess DNA damage. Cells defective in apoptosis tend to survive with excess DNA damage and thus allow DNA replication past DNA damages, causing mutations leading to carcinogenesis. It has recently become apparent that key proteins which contribute to cellular survival by acting in DNA repair become executioners in the face of excess DNA damage. Five major DNA repair pathways are homologous recombinational repair (HRR), non-homologous end joining (NHEJ), nucleotide excision repair (NER), base excision repair (BER) and mismatch repair (MMR). In each of these DNA repair pathways, key proteins occur with dual functions in DNA damage sensing/repair and apoptosis. Proteins with these dual roles occur in: (1) HRR (BRCA1, ATM, ATR, WRN, BLM, Tip60 and p53); (2) NHEJ (the catalytic subunit of DNA-PK); (3) NER (XPB, XPD, p53 and p33(ING1b)); (4) BER (Ref-1/Ape, poly(ADP-ribose) polymerase-1 (PARP-1) and p53); (5) MMR (MSH2, MSH6, MLH1 and PMS2). For a number of these dual-role proteins, germ line mutations causing them to be defective also predispose individuals to cancer. Such proteins include BRCA1, ATM, WRN, BLM, p53, XPB, XPD, MSH2, MSH6, MLH1 and PMS2.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“P53 is well known to be involved in the regulation of NER and apoptosis [ 51 – 53 ].”
Citations
Cites
1 retracted
BRCA1 required for transcription-coupled repair of oxidative DNA damage
Gowen, L. C., Avrutskaya, A. V., Latour, A. M., Koller, B. H., & Leadon, S. A. (1998) · Science · doi:10.1126/science.281.5379.1009 · Cited by 496 · cited 1×
“[277] L.”
Retractedp53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289 · cited 18×
“When XPD helicase function is defective due to an alteration in its ATP hydrolysis region, neither 5 nor 3 incisions in defined positions around a DNA adduct can be detected [178].”
BackgroundInfluentialBcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003 · cited 1×
“As Bcl-2 increases, Bax/Bcl-2 heterodimers predominate, and cells are protected from apoptosis [250,251].”
BackgroundInduction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c
Liu, X., Kim, C. N., Yang, J., Jemmerson, R., & Wang, X. (1996) · Cell · doi:10.1016/s0092-8674(00)80085-9 · Cited by 5,167 · cited 18×
“When XPD helicase function is defective due to an alteration in its ATP hydrolysis region, neither 5 nor 3 incisions in defined positions around a DNA adduct can be detected [178].”
BackgroundInfluentialPrevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T.-I., Jones, D. P., & Wang, X. (1997) · Science · doi:10.1126/science.275.5303.1129 · Cited by 4,911 · cited 2×
“Bcl-2 overexpression prevents the release of cytochrome c and ensuing events and thus mediates anti-apoptotic effects [248,249].”
BackgroundThe Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy-Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,714 · cited 1×
“Bcl-2 overexpression prevents the release of cytochrome c and ensuing events and thus mediates anti-apoptotic effects [248,249].”
BackgroundMdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · cited 1×
“p53 degradation is mediated by MDM2, a nuclear protein induced by p53 that binds to the p53 transactivation domain and promotes p53 degradation [235,236].”
BackgroundGenetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168 · cited 2×
“This instability occurs at two levels[12].”
BackgroundTumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063 · cited 1×
“Two distinct mechanisms by which p53 contributes to apoptosis are the transcriptional up-regulation of Bax[243]and direct interaction of p53 with mitochondria[47,244].”
Background
Cited by
Ageing as a Risk Factor for Disease
Niccoli, T., & Partridge, L. (2012) · Current Biology · doi:10.1016/j.cub.2012.07.024 · Cited by 1,831
“Many DDR components were first identified as tumour suppressors and patients harbouring DDR mutants are highly susceptible to cancer [96].”
BackgroundDNA damage and the balance between survival and death in cancer biology
Roos, W. P., Thomas, A. D., & Kaina, B. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.2 · Cited by 1,189
Degterev, A., Boyce, M., & Yuan, J. (2003) · Oncogene · doi:10.1038/sj.onc.1207107 · Cited by 1,107
Acetylation by Tip60 Is Required for Selective Histone Variant Exchange at DNA Lesions
Kusch, T., Florens, L., MacDonald, W. H., Swanson, S. K., Glaser, R. L., Yates, J. R., Abmayr, S. M., Washburn, M. P., & Workman, J. L. (2004) · Science · doi:10.1126/science.1103455 · Cited by 667
Bile acids as carcinogens in human gastrointestinal cancers
Bernstein, H., Bernstein, C., Payne, C. M., Dvorakova, K., & Garewal, H. (2005) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2004.08.001 · Cited by 611
Self-citation
Metadata
- Authors
- Bernstein, C.
- Affiliations
- University of Arizona (US)
- Corresponding author
- Bernstein, C
- ORCID
- Bernstein, C
- Venue
- Mutation Research/Reviews in Mutation Research
- Publisher
- Elsevier BV
- Published
- 2002-06
- Volume
- 511
- Issue
- 2
- Pages
- 145-178
- ISSN
- 1383-5742 (ISSN-L)
- OpenAlex
- W2113349101
- Cited by
- 527
- References
- 289
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 10 · 2023: 7 · 2022: 12 · 2021: 10 · 2020: 21 · 2019: 8 · 2018: 20 · 2017: 14 · 2016: 18 · 2015: 15 · 2014: 19 · 2013: 27 · 2012: 29
- FWCI
- 16.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Mutation Research/Reviews in Mutation Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ca065579-03)
- National Cancer Institute (CA 72008, CA 23074, CA65579, R01CA043894, P01CA072008, CA 43894, P30CA023074)
- National Institute of Environmental Health Sciences (ES 06694, P30ES006694)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- DNA repair, apoptosis, DNA damage recognition, carcinogenesis, genome stability, homologous recombination repair, non-homologous end joining, nucleotide excision repair, base excision repair, DNA mismatch repair, BRCA1, ATM, ATR, WRN, BLM, Tip60, p53, DNA-dependent protein kinase, XPB, XPD, PARP1, MSH2, MSH6, MLH1, PMS2, hereditary cancer predisposition, germline mutations
- MeSH terms
- Cell Cycle, DNA, DNA Damage, DNA Repair, Humans, Models, Biological, Neoplasms, Tumor Suppressor Protein p53, Apoptosis, Proto-Oncogene Proteins c-bcl-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. https://app.cochat.ai/papers/10.1016/s1383-5742(02)00009-1
- The paper
- Bernstein, C. (2002). DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutation Research/Reviews in Mutation Research. https://doi.org/10.1016/s1383-5742(02)00009-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.